0001127602-23-020573.txt : 20230711
0001127602-23-020573.hdr.sgml : 20230711
20230711173514
ACCESSION NUMBER: 0001127602-23-020573
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230707
FILED AS OF DATE: 20230711
DATE AS OF CHANGE: 20230711
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Loose Christopher R.
CENTRAL INDEX KEY: 0001785299
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39062
FILM NUMBER: 231082864
MAIL ADDRESS:
STREET 1: C/O FREQUENCY THERAPEUTICS, INC.
STREET 2: 19 PRESIDENTIAL WAY, 2ND FLOOR
CITY: WOBURN
STATE: MA
ZIP: 01801
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Frequency Therapeutics, Inc.
CENTRAL INDEX KEY: 0001703647
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472324450
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 75 HAYDEN AVENUE
STREET 2: SUITE 300
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-315-4600
MAIL ADDRESS:
STREET 1: 75 HAYDEN AVENUE
STREET 2: SUITE 300
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
form4.xml
PRIMARY DOCUMENT
X0407
4
2023-07-07
0001703647
Frequency Therapeutics, Inc.
FREQ
0001785299
Loose Christopher R.
C/O FREQUENCY THERAPEUTICS, INC.
75 HAYDEN AVE, SUITE 300
LEXINGTON
MA
02421
1
Chief Scientific Officer
1
Common Stock
2023-07-07
4
S
0
1306
.36
D
62781
D
Common Stock
2023-07-07
4
M
0
4546
A
67327
D
Common Stock
2023-07-10
4
S
0
1304
.37
D
66023
D
Common Stock
2023-07-10
4
M
0
4546
A
70569
D
Restricted Stock Unit
2023-07-07
4
M
0
4546
D
Common Stock
4546
136362
D
Restricted Stock Unit
2023-07-10
4
M
0
4546
D
Common Stock
4546
131816
D
Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.34 to $0.36. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
Includes 6,329 shares acquired under the Issuer's Employee Stock Purchase Plan on June 30, 2023.
Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.37 to $0.38. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
The restricted stock units will fully vest on July 4, 2023.
/s/ James P. Abely, Attorney-in-Fact for Christopher R. Loose
2023-07-11